Infarriks vaccine

Children in the process of their growth and development have too weak immunity, so they often suffer from various infectious diseases, such as diphtheria and pertussis, as well as poliomyelitis and tetanus. Therefore, in the first year of life (and in the future) vaccination is so necessary. It will help protect the child from the most dangerous infections and develop him or her immunity to this or that disease. Pertussis is too dangerous for young children: the likelihood of the disease is too high, it is very severe, the child may experience complications that lead to hemorrhages in the brain, especially in children under the age of one year. And tetanus, diphtheria and poliomyelitis can not be called trivial infections.

Infantricks vaccine: instructions for use

After they began to vaccinate children (DTP vaccine, Infanricks), such diseases as pertussis and diphtheria have risen very, very rarely. Although recently (due to massive refusals of vaccination), such ailments again "raise their heads." Currently, a new and fairly high-quality Infarriks vaccine is being used most often, which is produced in the UK by Glaxo Smith Klein. It is the first cell-free vaccine that contains only aculeulant pertussis antigen, which allows to significantly reduce the risks of complications and reactions after the introduction of serum, especially in young children.

Infanrix vaccine is also good, it can be used not only for primary vaccination, but for revaccination, including children older than 4 years. In some countries, such a vaccine has been used for a long time.

Infanrix vaccine exists in several forms.

The first one is Infanrix Hex. It is used to prevent diseases such as poliomyelitis, tetanus, diphtheria and whooping cough, as well as hepatitis B and hemophilic infection. Thus, one vaccine protects against six types of infections, hence the name "hexa." This vaccine contains tetanus and diphtheria antitoxins, purified pertussis antigens. It also includes inactivated polioviruses, purified surface antigen of hepatitis B and a number of other active substances. Such Infarriks vaccine can be given to children from the age of 6 weeks of life (usually from 3 months). Such a vaccination most often does not lead to significant deterioration in the child's well-being, however, as with the introduction of other vaccines, a fever, moods, pain at the injection site, general anxiety are possible.

The second type of vaccine, Infanrix IPV, consists of tetanus and diphtheria toxoids, as well as three purified pertussis antigens and three types of inoculated polioviruses. This vaccine is used to prevent poliomyelitis, whooping cough, tetanus and diphtheria. Begin to do it after three months of life of the baby, then conduct a revaccination at 18 months. This vaccine is intended for intramuscular administration. Many doctors recommend starting vaccination with Infanrix IPV, and continue with Infanrix Hex (due to the fact that more pronounced reactions are most often associated with the component against hemophilic infection).

Also, Infanrix vaccine exists in a "pure" form - in this case it protects only from tetanus, diphtheria and whooping cough. Most often it is combined with taking drops from poliomyelitis (OPV), but progressive doctors say that it is more appropriate to use the IPV vaccine (in prick).

The main contraindications to Infanrix vaccine are that children with high hypersensitivity to any type of vaccine should not be vaccinated, as well as children suffering from encephalopathy of unknown etiology.

All these vaccines performed well, due to the fact that they have an excellent preventive effect and are relatively easy to tolerate.